½ÃÀ庸°í¼­
»óǰÄÚµå
1672176

¼¼°èÀÇ Á¦¾à Çùµ¿·Îº¿ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2025-2033³â)

Global Pharmaceutical Collaborative Robots Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 147 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Á¦¾à Çùµ¿·Îº¿ ½ÃÀå ±Ô¸ð´Â 2024³â 8,590¸¸ ´Þ·¯¿¡¼­ 2033³â¿¡´Â 2¾ï 893¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2026-2033³âÀÇ ¿¹Ãø±â°£ µ¿¾È 10.38%ÀÇ °ß°íÇÑ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦¾à Çùµ¿·Îº¿(cobot) ½ÃÀåÀº ÀǾàǰ Á¦Á¶ ¹× ¿¬±¸ ¹æ¹ýÀÇ ÀÚµ¿È­ ¹× È¿À²È­¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Çùµ¿·Îº¿Àº Àΰ£ ÀÛ¾÷ÀÚ¿Í ÇÔ²² ÀÛ¾÷Çϵµ·Ï ¼³°èµÇ¾î ÀǾàǰÀÇ Á¦Á¦, Æ÷Àå, ǰÁú °ü¸® µîÀÇ ÀÛ¾÷¿¡¼­ »ý»ê¼º°ú Á¤È®¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. Á¦¾à¾÷°è°¡ ¾÷¹« ÃÖÀûÈ­¿Í ÀÎÀû ¿À·ù¸¦ ÁÙÀ̱â À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥, ÄÚº¿¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀº ²ÙÁØÈ÷ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ·Îº¿ ±â¼úÀÇ ¹ßÀüÀº ÀÇ·á¿ë Çùµ¿·Îº¿ ½ÃÀåÀÇ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. º¸´Ù Áøº¸µÈ ¼¾¼­, ÀΰøÁö´É, ¸Ó½Å·¯´× ±â´ÉÀÇ °³¹ß·Î ÄÚº¿ÀÇ ±â´É¼º°ú ÀûÀÀ¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº Á¦¾à °øÁ¤ÀÇ È¿À²¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó »ý»ê ¶óÀÎÀÇ À¯¿¬¼ºÀ» ³ô¿© º¯È­ÇÏ´Â ¼ö¿ä¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. Á¦¾à ·Îº¿ÀÇ »õ·Î¿î ¿ëµµ¿Í ±â¼ú ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó ¾÷¹« È¿À²¼º°ú ¾ÈÀü¼ºÀÌ Çâ»óµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ½ÃÀåÀº ´õ¿í È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ, Á¦¾à »ê¾÷¿¡¼­ ±ÔÁ¦ Áؼö¿Í ǰÁú º¸Áõ¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ Çùµ¿·Îº¿¿¡ ´ëÇÑ ±ÔÁ¦ ȯ°æÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ ±â°üÀÌ Á¦Á¶ °øÁ¤¿¡ ´õ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» µµÀÔÇÔ¿¡ µû¶ó ÀϰüµÈ ǰÁú°ú ÄÄÇöóÀ̾𽺸¦ º¸ÀåÇÒ ¼ö ÀÖ´Â ÄÚº¿¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Á¤È®¼º°ú ½Å·Ú¼ºÀÌ Áß¿ä½ÃµÇ´Â Áß¿äÇÑ È¯°æ¿¡¼­ ƯÈ÷ Áß¿äÇÏ°Ô ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Á¦¾à Çùµ¿·Îº¿ ½ÃÀåÀÌ °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, ±â¼ú ¹ßÀü, ±ÔÁ¦ ¾Ð·Â, È¿À²ÀûÀÎ Á¦Á¶ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ °áÇÕÇÏ¿© ¹Ì·¡ÀÇ ±Ëµµ¸¦ Çü¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.

´ç»çÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÏ°Ô ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇØ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò¸¦ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä : Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¼Ò°³.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ: ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, »õ·Î¿î Æ®·»µå µîÀÇ ¿äÀÎÀ» °ËÅäÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ÀáÀç·ÂÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æÀï ȯ°æ: ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê, À繫 ½ÇÀû µî ÁÖ¿ä ½ÃÀå ±â¾÷¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡. ÁÖ¿ä ±â¾÷µéÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ µ¿¾È ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» º¸¿©ÁÖ´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î Æ®·»µå¿Í ±âȸ: ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÐ¾ß¸¦ ÆÄ¾ÇÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³Ã´ ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå Á¦¾à Çùµ¿·Îº¿ »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ Á¦¾à Çùµ¿·Îº¿ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ¿ëµµº°
  • ÇÇÅ· ¹× Æ÷Àå
  • ÀǾàǰ °Ë»ç
  • ¿¬±¸½Ç

Á¦6Àå ¼¼°èÀÇ Á¦¾à Çùµ¿·Îº¿ ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • °³¿ä : ÃÖÁ¾ ¿ëµµº°
  • °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
  • Á¦¾àȸ»ç
  • ¿¬±¸¼Ò
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ Á¦¾à Çùµ¿·Îº¿ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ºÏ¹Ì ºÎ¹®º°
    • ºÏ¹Ì ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • À¯·´ ºÎ¹®º°
    • À¯·´ ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° ¸®½ºÆ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå Á¦¾à Çùµ¿·Îº¿ ±â¾÷ °æÀï ±¸µµ

  • Á¦¾à Çùµ¿·Îº¿ ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • ABB
  • Universal Robots A/S(Teradyne)
  • Mitsubishi Electric Corporation
  • Kuka AG(Midea Group)
  • Kawasaki Heavy Industries Ltd.
  • Yaskawa Electric Corporation
  • DENSO WAVE Incorporated
  • FANUC America Corporation
  • OMRON Corporation
  • Seiko Epson Corporation
LSH 25.04.11

Global Pharmaceutical Collaborative Robots Market size is anticipated to grow from USD 85.9 Million in 2024 to USD 208.93 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 10.38% during the forecast period of 2026 to 2033.

The pharmaceutical collaborative robots (cobots) market is experiencing significant growth, driven by the increasing demand for automation and efficiency in pharmaceutical manufacturing and research processes. Collaborative robots are designed to work alongside human operators, enhancing productivity and precision in tasks such as drug formulation, packaging, and quality control. As the pharmaceutical industry seeks to optimize operations and reduce human error, the demand for cobots is expected to rise, positioning this market for robust expansion.

Moreover, advancements in robotics technology are propelling innovation within the pharmaceutical collaborative robots market. The development of more sophisticated sensors, artificial intelligence, and machine learning capabilities is enhancing the functionality and adaptability of cobots. These innovations not only improve the efficiency of pharmaceutical processes but also enable greater flexibility in production lines, allowing for quick adjustments to meet changing demands. As research continues to explore new applications and technologies in pharmaceutical robotics, the market is likely to expand further, driven by the promise of enhanced operational efficiency and safety.

Additionally, the growing emphasis on regulatory compliance and quality assurance in the pharmaceutical industry is shaping the collaborative robots landscape. As regulatory bodies implement stricter guidelines for manufacturing processes, the demand for cobots that can ensure consistent quality and compliance is likely to increase. This trend is particularly relevant in the context of high-stakes environments, where precision and reliability are critical. As the pharmaceutical collaborative robots market continues to evolve, the combination of technological advancements, regulatory pressures, and the need for efficient manufacturing solutions will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

  • Picking and Packaging
  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications
  • By-End-use
  • Pharmaceutical Companies
  • Research Laboratories
  • COMPANIES PROFILED
  • ABB
  • Universal Robots A/S (Teradyne)
  • Mitsubishi Electric Corporation
  • Kuka AG (Midea Group)
  • Kawasaki Heavy Industries Ltd.
  • Yaskawa Electric Corporation
  • DENSO WAVE INCORPORATED
  • FANUC America Corporation
  • OMRON CORPORATION
  • Seiko Epson Corporation
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PHARMACEUTICAL COLLABORATIVE ROBOTS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHARMACEUTICAL COLLABORATIVE ROBOTS MARKET ANALYSIS BY APPLICATION

  • 5.1. Overview By Application
  • 5.2. Historical and Forecast Data Analysis By Application
  • 5.3. Picking and Packaging Historic and Forecast Sales By Regions
  • 5.4. Inspection of Pharmaceutical Drugs Historic and Forecast Sales By Regions
  • 5.5. Laboratory Historic and Forecast Sales By Regions

6. GLOBAL PHARMACEUTICAL COLLABORATIVE ROBOTS MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-use
  • 6.2. Historical and Forecast Data Analysis By End-use
  • 6.3. Pharmaceutical Companies Historic and Forecast Sales By Regions
  • 6.4. Research Laboratories Historic and Forecast Sales By Regions
  • 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL PHARMACEUTICAL COLLABORATIVE ROBOTS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL COLLABORATIVE ROBOTS COMPANIES

  • 8.1. Pharmaceutical Collaborative Robots Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF PHARMACEUTICAL COLLABORATIVE ROBOTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. ABB
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Universal Robots A/S (Teradyne)
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Mitsubishi Electric Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Kuka AG (Midea Group)
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Kawasaki Heavy Industries Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Yaskawa Electric Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. DENSO WAVE Incorporated
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. FANUC America Corporation
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. OMRON Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Seiko Epson Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦